Report cover image

Antibiotics Market

Publisher Evolve Business Intelligence
Published Apr 14, 2025
SKU # EVBI19932168

Description

The Antibiotics Market is projected to reach USD 41.65 billion by 2033, up from USD 32.54 billion in 2023, with an anticipated compound annual growth rate (CAGR) of 1.65% from 2023 to 2033. This market encompasses the global demand for pharmaceutical products aimed at treating bacterial infections, including a variety of antibacterial drugs such as penicillins, cephalosporins, macrolides, fluoroquinolones, and tetracyclines. The increasing prevalence of infectious diseases and the need for effective treatments are key drivers of market growth. Broad-spectrum antibiotics, such as amoxicillin and levofloxacin, play a particularly significant role. Additionally, the market is expected to grow at a CAGR of 5.67% from 2023 to 2028, driven by factors such as heightened awareness of disease detection and treatment, favorable regulatory designations, and ongoing clinical trials aimed at combating antibiotic resistance.

The latest research report by Evolve Business Intelligence explores the various factors influencing the global market. It includes an analysis of the current market size, forecasts for key segments and regions, and the driving forces behind market growth. The report examines the potential impacts of key trends on business strategies and provides a SWOT analysis of critical sectors for each major competitor and customer group. This valuable data highlights the conglomerates likely to impact the industry, crucial for any company planning to invest strategically over the next five years. These insights complement our initial quantitative study, aiding in new investments and strategic planning to mitigate threats in existing sectors.

Segments covered

By Class (Beta Lactam & Beta Lactamase Inhibitors, Quinolone, Macrolide, Others)
By Drug Origin (Natural, Semisynthetic, Synthetic)
By Spectrum of Activity (Broad-spectrum Antibiotic, Narrow-spectrum Antibiotic)

Key players

Abbott Laboratories
Allergan Plc
HOFFMANN-LA ROCHE LTD.
GlaxoSmithKline Plc
Merck & Co. Inc
Mylan N.V
Novartis International AG
Pfizer Inc
Teva Pharmaceutical Industries Ltd.
Sanofi

Table of Contents

CHAPTER 1. Executive Summary
CHAPTER 2. Scope of the Study
2.1. Market Definition
2.2. Market Scope & Segmentation
2.2.1. Objective of Report
CHAPTER 3. Evolve BI Methodology
3.1. Data Collection & Validation Approach
3.2. Market Size Estimation and Forecast
CHAPTER 4. Exclusive Analysis
4.1. Market Opportunity Score
4.1.1. Class Segement – Market Opportunity Score
4.1.2. Drug Origin Segment – Market Opportunity Score
4.1.3. Spectrum of Activity Segment – Market Opportunity Score
4.2. Key Market Influencing Indicators
CHAPTER 5. Market Insights and Trends
5.1. Value Chain Analysis
5.1.1. Raw Material
5.1.2. Manufacturing Process
5.1.3. Distribution Channel
5.1.4. End User
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Buyers
5.2.2. Bargaining Power of Suppliers
5.2.3. Threat of New Entrant
5.2.4. Threat of Substitute
5.2.5. Industry Rivalry
5.3. COVID-19 Impact and Post COVID Scenario on Antibiotics Market
5.3.1. Impact of COVID-19
5.3.2. Government Support and Industry Revival Policies
5.3.3. Measures Taken by Companies to Mitigate Negative Impact
5.3.4. Post COVID Trend
CHAPTER 6. MArket Dynamics
6.1. Introduction
6.2. Drivers
6.2.1. Driver 1
6.2.2. Driver 2
6.2.3. Driver 3
6.3. Restraints
6.3.1. Restraint 1
6.3.2. Restraint 2
6.4. Opportunity
6.4.1. Opportunity 1
CHAPTER 7. Global Antibiotics Market, By Class
7.1. Introduction
7.1.1. Beta Lactam & Beta Lactamase Inhibitors
7.1.2. Quinolone
7.1.3. Macrolide
7.1.4. Others
CHAPTER 8. Global Antibiotics Market, By Drug Origin
8.1. Introduction
8.1..1. Natural
8.1.2. Semisynthetic
8.1.3. Synthetic
8.1.4. Drug Origin
CHAPTER 9. Global Antibiotics Market, By Spectrum of Activity
9.1. Introduction
9.1.1. Broad-spectrum Antibiotic
9.1.2. Narrow-spectrum Antibiotic
CHAPTER 10. Global Antibiotics Market, By Region
10.1. Introduction
10.2. NORTH AMERICA
10.2.1. North America: Market Size and Forecast, By Country, 2023 – 2033 ($ Million)
10.2.2. North America: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)
10.2.3. North America: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)
10.2.4. North America: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)
10.2.5. US
10.2.5.1. US: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)
10.2.5.2. US: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)
10.2.5.3. US: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)
10.2.6. CANADA
10.2.6.1. Canada: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)
10.2.6.2. Canada: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)
10.2.6.3. Canada: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)
10.2.7. MEXICO
10.2.7.1. Mexico: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)
10.2.7.2. Mexico: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)
10.2.7.3. Mexico: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)
10.3. Europe
10.3.1. Europe: Market Size and Forecast, By Country, 2023 – 2033 ($ Million)
10.3.2. Europe: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)
10.3.3. Europe: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)
10.3.4. Europe: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)
10.3.5. U.K.
10.3.5.1. U.K.: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)
10.3.5.2. U.K.: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)
10.3.5.3. U.K.: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)
10.3.6. GERMANY
10.3.6.1. Germany: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)
10.3.6.2. Germany: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)
10.3.6.3. Germany: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)
10.3.7. FRANCE
10.3.7.1. France: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)
10.3.7.2. France: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)
10.3.7.3. France: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)
10.3.8. ITALY
10.3.8.1. Italy: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)
10.3.8.2. Italy: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)
10.3.8.3. Italy: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)
10.3.9. SPAIN
10.3.9.1. Spain: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)
10.3.9.2. Spain: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)
10.3.9.3. Spain: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)
10.3.10. BENELUX
10.3.10.1. BeNeLux: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)
10.3.10.2. BeNeLux: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)
10.3.10.3. BeNeLux: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)
10.3.11. RUSSIA
10.3.11.1. Russia: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)
10.3.11.2. Russia: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)
10.3.11.3. Russia: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)
10.3.12. REST OF EUROPE
10.3.12.1. Rest of Europe: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)
10.3.12.2. Rest of Europe: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)
10.3.12.3. Rest of Europe: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)
10.4. Asia Pacific
10.4.1. Asia Pacific: Market Size and Forecast, By Country, 2023 – 2033 ($ Million)
10.4.2. Asia Pacific: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)
10.4.3. Asia Pacific: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)
10.4.4. Asia Pacific: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)
10.4.5. CHINA
10.4.5.1. China: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)
10.4.5.2. China: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)
10.4.5.3. China: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)
10.4.6. JAPAN
10.4.6.1. Japan: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)
10.4.6.2. Japan: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)
10.4.6.3. Japan: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)
10.4.7. INDIA
10.4.7.1. India: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)
10.4.7.2. India: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)
10.4.7.3. India: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)
10.4.8. SOUTH KOREA
10.4.8.1. South Korea: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)
10.4.8.2. South Korea: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)
10.4.8.3. South Korea: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)
10.4.9. THAILAND
10.4.9.1. Thailand: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)
10.4.9.2. Thailand: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)
10.4.9.3. Thailand: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)
10.4.10. INDONESIA
10.4.10.1. Indonesia: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)
10.4.10.2. Indonesia: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)
10.4.10.3. Indonesia: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)
10.4.11. MALAYSIA
10.4.11.1. Malaysia: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)
10.4.11.2. Malaysia: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)
10.4.11.3. Malaysia: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)
10.4.12. AUSTRALIA
10.4.12.1. Australia: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)
10.4.12.2. Australia: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)
10.4.12.3. Australia: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)
10.4.13. REST FO ASIA PACIFIC
10.4.13.1. Rest fo Asia Pacific: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)
10.4.13.2. Rest fo Asia Pacific: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)
10.4.13.3. Rest fo Asia Pacific: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)
10.5. South America
10.5.1. South America: Market Size and Forecast, By Country, 2023 – 2033 ($ Million)
10.5.2. South America: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)
10.5.3. South America: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)
10.5.4. South America: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)
10.5.5. BRAZIL
10.5.5.1. Brazil: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)
10.5.5.2. Brazil: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)
10.5.5.3. Brazil: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)
10.5.6. ARGENTINA
10.5.6.1. Argentina: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)
10.5.6.2. Argentina: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)
10.5.6.3. Argentina: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)
10.5.7. REST OF SOUTH AMERICA
10.5.7.1. Rest of South America: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)
10.5.7.2. Rest of South America: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)
10.5.7.3. Rest of South America: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)
10.6. Middle East & Africa
10.6.1. Middle East & Africa: Market Size and Forecast, By Country, 2023 – 2033 ($ Million)
10.6.2. Middle East & Africa: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)
10.6.3. Middle East & Africa: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)
10.6.4. Middle East & Africa: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)
10.6.5. SAUDI ARABIA
10.6.5.1. Saudi Arabia: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)
10.6.5.2. Saudi Arabia: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)
10.6.5.3. Saudi Arabia: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)
10.6.6. UAE
10.6.6.1. UAE: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)
10.6.6.2. UAE: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)
10.6.6.3. UAE: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)
10.6.7. EGYPT
10.6.7.1. Egypt: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)
10.6.7.2. Egypt: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)
10.6.7.3. Egypt: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)
10.6.8. SOUTH AFRICA
10.6.8.1. South Africa: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)
10.6.8.2. South Africa: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)
10.6.8.3. South Africa: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)
10.6.9. REST OF MIDDLE EAST & AFRICA
10.6.9.1. Rest of Middle East & Africa: Market Size and Forecast, By Class, 2023 – 2033 ($ Million)
10.6.9.2. Rest of Middle East & Africa: Market Size and Forecast, By Drug Origin, 2023 – 2033 ($ Million)
10.6.9.3. Rest of Middle East & Africa: Market Size and Forecast, By Spectrum of Activity, 2023 – 2033 ($ Million)
CHAPTER 12. Competitive Landscape
12.1. Competitior Benchmarking 2023
12.2. Market Share Analysis
12.3. Key Developments Analysis By Top 5 Companies
12.4. Market Share Acquisition Strategies: Analysis of Key Approaches Employed by Top Players
CHAPTER 13. Company Profiles
13.1. Abbott Laboratories
13.1.1. Business Overview
13.1.2. Financial Analysis
13.1.2.1. Business Segment Revenue, 2020, 2021, 2022, $ Million
13.1.2.2. Geographic Revenue Mix, 2022 (% Share)
13.1.3. Product Portfolio
13.1.4. Recent Development and Strategies Adopted
13.1.5. SWOT Analysis
13.2. Allergan Plc
13.3. HOFFMANN-LA ROCHE LTD.
13.4. GlaxoSmithKline Plc
13.5. Merck & Co. Inc
13.6. Mylan N.V
13.7. Novartis International AG
13.8. Pfizer Inc
13.9. Teva Pharmaceutical Industries Ltd.
13.10. Sanofi

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us